Nrg Lu-002: Maintenance Systemic Therapy Versus Consolidative Sterotactic Body Radiation Therapy (Sbrt) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer (Nsclc): A Randomized Phase II/III Trial
Posted Date: Jun 17, 2019
- Investigator: Emily Daugherty
- Specialties: Cancer, Lung Cancer, Oncology, Radiation Oncology
- Type of Study: Drug
To goal of this study is to evaluate the impact of adding LCT (local consolidative therapy) to maintenance systemic therapy versus maintenance systemic therapy alone on progression-free survival for patients with metastatic NSCLC with no evidence of progression and limited metastatic sites after first-line systemic therapy
Criteria:
To Be Eligible: Stage Iv Non-Small Cell Lung Cancer With 3 Or Less Areas Of Metastatic Cancer Spread Aged 18 Years Or Older
Keywords:
Lung Cancer, Metastatic, Radiation Therapy
For More Information:
Dr. Emily Daugherty, Md
513-584-7698
cancer@uchealth.com